Divergent Resorbability and Effects on Osteoclast Formation of Commonly Used Bone Substitutes in a Human In Vitro-Assay
暂无分享,去创建一个
Arndt F. Schilling | Michael Amling | Björn Busse | T. Lange | A. Schilling | M. Amling | B. Busse | T. Schinke | Thorsten Schinke | Tobias Lange | Silja Brink | Johannes Keller | J. Keller | S. Brink
[1] Greer Rb rd. Wolff's Law. , 1993 .
[2] D. Sohn,et al. A Method of Sealing Perforated Sinus Membrane and Histologic Finding of Bone Substitutes: A Case Report , 2005, Implant dentistry.
[3] K. Aoki,et al. Three-dimensional characterization of osteoclast bone-resorbing activity in the resorption lacunae. , 2009, Journal of medical and dental sciences.
[4] R E Booth,et al. Harvesting Autogenous Iliac Bone Grafts: A Review of Complications and Techniques , 1989, Spine.
[5] R C Edwards,et al. The fate of resorbable poly-L-lactic/polyglycolic acid (LactoSorb) bone fixation devices in orthognathic surgery. , 2001, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.
[6] T. Uemura,et al. Laser microscopic measurement of osteoclastic resorption pits on biomaterials , 2007 .
[7] S. J. Jones,et al. The relationship between the number of nuclei of an osteoclast and its resorptive capability in vitro , 1992, Anatomy and Embryology.
[8] M. Raška,et al. Bone remodeling, particle disease and individual susceptibility to periprosthetic osteolysis. , 2008, Physiological research.
[9] T. Gotterbarm,et al. The efficacy of Biobon™ and Ostim™ within metaphyseal defects using the Göttinger Minipig , 2009, Archives of Orthopaedic and Trauma Surgery.
[10] J. Risteli,et al. Estrogen Reduces the Depth of Resorption Pits by Disturbing the Organic Bone Matrix Degradation Activity of Mature Osteoclasts. , 2001, Endocrinology.
[11] W. Linhart,et al. [Treatment of metaphyseal bone defects after fractures of the distal radius. Medium-term results using a calcium-phosphate cement (BIOBON)]. , 2003, Der Unfallchirurg.
[12] M. Reinhold,et al. Successful posterior interlaminar fusion at the thoracic spine by sole use of β-tricalcium phosphate , 2006, Archives of Orthopaedic and Trauma Surgery.
[13] S. Meyer,et al. Histological osseointegration of Tutobone®: first results in human , 2008, Archives of Orthopaedic and Trauma Surgery.
[14] D. Weerakoon. SAFTA: Current Status and Prospects , 2010 .
[15] M. Rauschmann,et al. Effectiveness of Combination Use of Antibiotic-Loaded PerOssal® with Spinal Surgery in Patients with Spondylodiscitis , 2009, European Surgical Research.
[16] A. Rack,et al. Effect of beta-tricalcium phosphate particles with varying porosity on osteogenesis after sinus floor augmentation in humans. , 2008, Biomaterials.
[17] T. Bauer,et al. Bone graft substitutes , 2007, Skeletal Radiology.
[18] D. Williams,et al. Immune response in biocompatibility. , 1992, Biomaterials.
[19] J. David,et al. TNF and bone. , 2010, Current directions in autoimmunity.
[20] J. Heersche,et al. Effect of medium pH on osteoclast activity and osteoclast formation in cultures of dispersed rabbit osteoclasts , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[21] E. Nkenke,et al. Bone regeneration in osseous defects-application of particulated human and bovine materials. , 2008, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.
[22] J. Jansen,et al. Histological evaluation of the bone response to calcium phosphate cement implanted in cortical bone. , 2003, Biomaterials.
[23] P. Buma,et al. Mechanism of bone incorporation of beta-TCP bone substitute in open wedge tibial osteotomy in patients. , 2005, Biomaterials.
[24] J. V. D. van den Bergh,et al. Maxillary sinus floor augmentation using a beta-tricalcium phosphate (Cerasorb) alone compared to autogenous bone grafts. , 2005, The International journal of oral & maxillofacial implants.
[25] R. Sader,et al. Synthetic, pure-phase beta-tricalcium phosphate ceramic granules (Cerasorb) for bone regeneration in the reconstructive surgery of the jaws. , 2006, International journal of oral and maxillofacial surgery.
[26] M. Morlock,et al. Proinflammatory and osteoclastogenic effects of beta-tricalciumphosphate and hydroxyapatite particles on human mononuclear cells in vitro. , 2009, Biomaterials.
[27] T. Lange,et al. Size dependent induction of proinflammatory cytokines and cytotoxicity of particulate beta-tricalciumphosphate in vitro. , 2011, Biomaterials.
[28] Rueger Jm. Bone substitution materials. Current status and prospects , 1998 .
[29] A. Horvai,et al. Metabolic bone diseases. , 2011, Seminars in diagnostic pathology.
[30] C. Ruff,et al. Who's afraid of the big bad Wolff?: "Wolff's law" and bone functional adaptation. , 2006, American journal of physical anthropology.
[31] P. Meeder,et al. Minimally Invasive Reduction and Internal Stabilization of Osteoporotic Vertebral Body Fractures (Balloon Kyphoplasty) , 2005, European Journal of Trauma.
[32] Matthias Epple,et al. Biological and medical significance of calcium phosphates. , 2002, Angewandte Chemie.
[33] T. Miclau,et al. Autologous iliac crest bone graft: should it still be the gold standard for treating nonunions? , 2007, Injury.
[34] W. Tomford,et al. Transmission of disease through transplantation of musculoskeletal allografts. , 1995, The Journal of bone and joint surgery. American volume.
[35] O. Kilian,et al. Enhancement of bone formation in hydroxyapatite implants by rhBMP-2 coating. , 2008, Journal of biomedical materials research. Part B, Applied biomaterials.
[36] J. Rueger. [Bone substitution materials. Current status and prospects]. , 1998, Der Orthopade.
[37] Ann M. Trousdale. Who's afraid of the big, bad wolf? , 1989 .
[38] A. Schilling,et al. Resorbability of bone substitute biomaterials by human osteoclasts. , 2004, Biomaterials.
[39] P. Heini,et al. Bone substitutes in vertebroplasty , 2001, European Spine Journal.